课题基金 / 基金详情

Role of Innate and Adaptive Immune Systems in Drug-Induced Liver Disease

Role of Innate and Adaptive Immune Systems in Drug-Induced Liver Disease
先天性和适应性免疫系统在药物性肝病中的作用
批准号:
8344879
负责人:
Lance R Pohl
金额:
$49.54万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Lance R Pohl的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Last year we found that regulatory T cells infiltrated into the liver of female Balb/cJ mice following halothane treatment and inhibited both humoral and cellular immune reactions against trifluoroacetylated proteins formed in vivo following halothane treatment. This year we report that newly discovered myeloid-derived suppressor cells also infiltrated into the liver of female Balb/cJ mice following halothane treatment. These cells have be shown recently to inhibit effector T cell activity in tumors, infections, and in autoimmune diseases. Conclusion: These findings suggest that both regulatory T cells and myeloid-derived suppressor cells might have a role in preventing drug-protein adducts from causing liver injury mediated by the adaptive immune system and that deficiencies in the activities of these regulatory cells might be susceptibility factors in DILD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms Of Drug-induced Toxicities
Mechanisms of Drug-Induced Liver Disease
Mechanisms of Drug-Induced Liver Disease
Mechanisms Of Drug-induced Toxicities
海外基金